Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""mutation"" wg kryterium: Temat

  Lista filtrów

Ogranicz do:

Wyrównaj
Wyświetlanie 1-20 z 1058
Tytuł:
[Analysis of the clinical characteristics of acute myeloid leukemia related to the treatment of hematological and solid tumors].
Autorzy:
Jiao Y; Department of Clinical Laboratory, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou Key Laboratory of Digestive Tumor Markers, Zhengzhou 450008, China.
Jiang YH; Department of Clinical Laboratory, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou Key Laboratory of Digestive Tumor Markers, Zhengzhou 450008, China.
Liu B; Department of Clinical Laboratory, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou Key Laboratory of Digestive Tumor Markers, Zhengzhou 450008, China.
Mi RH; Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou 450008, China.
Bi LJ; Key Laboratory of RNA Biology, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.
Xu QX; Department of Clinical Laboratory, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou Key Laboratory of Digestive Tumor Markers, Zhengzhou 450008, China.
Pokaż więcej
Źródło:
Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2024 Jan 23; Vol. 46 (1), pp. 86-95.
Typ publikacji:
English Abstract; Journal Article
MeSH Terms:
Leukemia, Myeloid, Acute*/drug therapy
Leukemia, Myeloid, Acute*/genetics
Hematologic Neoplasms*
Hematology*
Humans ; Retrospective Studies ; Mutation
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
[Chinese expert consensus on immunotherapy for advanced non-small lung cancer with oncogenic driver mutations (2023 edition)].
Corporate Authors:
Society of Cancer Precision Medicine of Chinese Anti-Cancer Association
Lung Cancer Expert Group of Chinese Medical Journal
Źródło:
Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2023 Sep 23; Vol. 45 (9), pp. 717-740.
Typ publikacji:
English Abstract; Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Immunotherapy*
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Humans ; Consensus ; Mutation ; Tumor Microenvironment ; China
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
[Effectiveness of tyrosine kinase inhibitors against non-small cell lung cancer patients with postoperative recurrence harboring uncommon EGFR mutations].
Autorzy:
Yang WJ; Department of Thoracic Surgery, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100021, China.
Gao YB; Department of Thoracic Surgery, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100021, China.
Qiu T; Department of Pathology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100021, China.
Wang YG; Department of Thoracic Surgery, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100021, China.
He J; Department of Thoracic Surgery, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100021, China.
Pokaż więcej
Źródło:
Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2017 Oct 23; Vol. 39 (10), pp. 732-736.
Typ publikacji:
Journal Article
MeSH Terms:
Mutation*
Antineoplastic Agents/*therapeutic use
Carcinoma, Non-Small-Cell Lung/*drug therapy
Carcinoma, Non-Small-Cell Lung/*genetics
ErbB Receptors/*genetics
Lung Neoplasms/*drug therapy
Lung Neoplasms/*genetics
Neoplasm Recurrence, Local/*drug therapy
Neoplasm Recurrence, Local/*genetics
Protein Kinase Inhibitors/*therapeutic use
Asian People ; Carcinoma, Non-Small-Cell Lung/mortality ; Carcinoma, Non-Small-Cell Lung/surgery ; Exons ; Female ; Humans ; Lung Neoplasms/mortality ; Lung Neoplasms/surgery ; Male ; Mutagenesis, Insertional ; Neoplasm Recurrence, Local/mortality ; Point Mutation ; Postoperative Period ; Prognosis ; Retrospective Studies ; Time Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
构建铜死亡相关LncRNA风险模型预测肝细胞癌的 预后及分子特征.
Autorzy:
王 硕
白红艳
费素娟
苗 蓓
Pokaż więcej
Alternatywny tytuł:
Construction of a Cuproptosis-related LncRNA Risk Model to Predict the Prognosis and Molecular Characteristics of Hepatocellular Carcinoma.
Źródło:
Journal of Laser Biology / Acta Laser Biology Sinica. Aug2023, Vol. 32 Issue 4, p330-344. 15p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
[Application of genetic counseling and preventive surgery in hereditary breast-ovarian cancer syndrome based on a rare family].
Autorzy:
Liu SH; Department of Gynecologic Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Dong L; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Li B; Department of Gynecologic Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Zhao D; Department of Gynecologic Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Ying JM; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Pokaż więcej
Źródło:
Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2023 Sep 23; Vol. 45 (9), pp. 796-802.
Typ publikacji:
English Abstract; Journal Article
MeSH Terms:
Breast Neoplasms*/genetics
Breast Neoplasms*/prevention & control
Breast Neoplasms*/surgery
Ovarian Neoplasms*/genetics
Ovarian Neoplasms*/prevention & control
Ovarian Neoplasms*/surgery
Humans ; Female ; Middle Aged ; Adult ; Genetic Counseling ; Genetic Predisposition to Disease ; Mutation
SCR Disease Name:
Breast Cancer, Familial
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
[Next generation sequencing technology for susceptible gene screening in familial non-medullary thyroid carcinoma].
Autorzy:
Dong L; Department of Thyroid and Neck Tumors, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.
Yu Y; Department of Thyroid and Neck Tumors, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.
Yu JP; Cancer Molecular Diagnostic Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin 300060, China.
Hao WJ; Department of Thyroid and Neck Tumors, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.
Zheng XQ; Department of Thyroid and Neck Tumors, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.
Cheng YN; Cancer Molecular Diagnostic Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin 300060, China.
Han L; Cancer Molecular Diagnostic Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin 300060, China.
Zhao JZ; Department of Thyroid and Neck Tumors, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.
Gao M; Department of Thyroid and Neck Tumors, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.
Pokaż więcej
Źródło:
Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2017 Jan 23; Vol. 39 (1), pp. 24-28.
Typ publikacji:
Journal Article
MeSH Terms:
Mutation*
Carcinoma/*genetics
High-Throughput Nucleotide Sequencing/*methods
Thyroid Neoplasms/*genetics
Carcinoma/pathology ; Carcinoma/secondary ; DNA Mutational Analysis ; Female ; Germ-Line Mutation ; Humans ; Lymphatic Metastasis ; Male ; Thyroid Neoplasms/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
[Expert consensus on the diagnosis and treatment in advanced non-small cell lung cancer with BRAF mutation in China].
Corporate Authors:
Lung Cancer Professional Committee of Chinese Anti-Cancer Association
Źródło:
Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2023 Apr 23; Vol. 45 (4), pp. 279-290.
Typ publikacji:
English Abstract; Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/diagnosis
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Lung Neoplasms*/diagnosis
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Humans ; Proto-Oncogene Proteins B-raf/genetics ; Consensus ; Mutation
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
[Chinese multidisciplinary expert consensus on the management of adverse drug reactions associated with savolitinib].
Autorzy:
Zhang L; Department of Respiratory, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100005, China.
Wang YS; Department of Oncology, West China Hospital, Sichuan University, Chengdu 610044, China.
Lin LZ; Department of Oncology, the First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510405, China.
Yu YF; Department of Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China.
Lu S; Department of Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China.
Pokaż więcej
Źródło:
Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2023 Apr 23; Vol. 45 (4), pp. 298-312.
Typ publikacji:
English Abstract; Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Lung Neoplasms*/pathology
Drug-Related Side Effects and Adverse Reactions*
Humans ; Consensus ; Quality of Life ; Proto-Oncogene Proteins c-met/genetics ; Protein Kinase Inhibitors/adverse effects ; Mutation
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
[Analysis of gene mutation profile of adult soft tissue sarcomas using high-throughput sequencing technology].
Autorzy:
Xu SF; Department of Orthopedics, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100021, China.
Wang WW; Thorgene Co., Ltd., Beijing 100176, China.
Chen J; BoAo BioTech Group Co., Ltd., Beijing 100176, China.
Liu T; Department of Orthopedics, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100021, China.
Zhang XX; Department of Orthopedics, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100021, China.
Xu LB; Department of Orthopedics, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100021, China.
Zhao ZG; Department of Orthopedics, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100021, China.
Yu SJ; Department of Orthopedics, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100021, China.
Guo LX; BoAo BioTech Group Co., Ltd., Beijing 100176, China.
Pokaż więcej
Źródło:
Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2020 Sep 23; Vol. 42 (9), pp. 741-745.
Typ publikacji:
Journal Article
MeSH Terms:
DNA Copy Number Variations*
Mutation*
Sarcoma*/genetics
Adult ; High-Throughput Nucleotide Sequencing ; Humans ; Phosphatidylinositol 3-Kinases ; Technology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
[Driver genes expression and clinical characteristics of targeted therapy in non-small cell lung cancer in Yunnan-Kweichow Plateau].
Autorzy:
Lin YP; Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Office of Yunnan Cancer Center, Kunming 650118, China.
Li Q; Yunnan Cancer Hospital, Molecular Diagnostic Branch Center of Yunnan Cancer Center, Kunming 650118, China.
Ma LY; Yunnan Provincial Key Laboratory of Lung Cancer, Kunming 650118, China.
Liu X; Joint Laboratory for International Cooperation of Plateau Regional High-Rise Cancer of Ministry of Education, Kunming 650118, China.
Dai M; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Wang XX; Joint Laboratory for International Cooperation of Plateau Regional High-Rise Cancer of Ministry of Education, Kunming 650118, China.
Li HS; Yunnan Cancer Hospital, Molecular Diagnostic Branch Center of Yunnan Cancer Center, Kunming 650118, China.
Liu JX; Yunnan Cancer Hospital, Molecular Diagnostic Branch Center of Yunnan Cancer Center, Kunming 650118, China.
Shen ZH; Yunnan Cancer Hospital, Molecular Diagnostic Branch Center of Yunnan Cancer Center, Kunming 650118, China.
Guo YJ; Yunnan Provincial Key Laboratory of Lung Cancer, Kunming 650118, China.
Du YX; Joint Laboratory for International Cooperation of Plateau Regional High-Rise Cancer of Ministry of Education, Kunming 650118, China.
Yang RJ; Yunnan Provincial Key Laboratory of Lung Cancer, Kunming 650118, China.
Huang YC; Yunnan Cancer Hospital, Molecular Diagnostic Branch Center of Yunnan Cancer Center, Kunming 650118, China.
Zhou YC; Yunnan Cancer Hospital, Molecular Diagnostic Branch Center of Yunnan Cancer Center, Kunming 650118, China.
Pokaż więcej
Źródło:
Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2020 Sep 23; Vol. 42 (9), pp. 735-740.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Mutation*
China ; Female ; Gene Expression ; Humans ; Male ; Molecular Targeted Therapy ; Proto-Oncogene Mas ; Proto-Oncogene Proteins/metabolism ; Proto-Oncogene Proteins p21(ras) ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
[The research status and development trend of EGFR gene exon 20 insertion mutant non-small cell lung cancer].
Autorzy:
Yang GJ; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Wang Y
Pokaż więcej
Źródło:
Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2020 Jan 23; Vol. 42 (1), pp. 22-29.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/genetics
Lung Neoplasms*/genetics
Mutation*
ErbB Receptors/genetics ; Exons ; Genes, erbB-1 ; Humans ; Protein Kinase Inhibitors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 1-20 z 1058

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies